Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Insulin for Treating Posttraumatic Stress Disorder

NCT04044534 is registered in ClinicalTrials.gov with VA Connecticut Healthcare System as lead sponsor.

NCT NCT04044534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04044534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Insulin for Treating Posttraumatic Stress Disorder
Lead sponsor
VA Connecticut Healthcare System
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2024
Completion date
May 28, 2026
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ptsd